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The purpose of this study was to evaluate a novel method of instituting quality 
improvement among hospitals in the area of smoking cessation through publicizing poor 
performance. Smoking cessation was used as an indicator due to its impact on the health 
of our population, evidence base and also because of availability of data. The Joint 
Commission on Accreditation of Healthcare Organizations (JCAHO) specified “smoking 
cessation advice and counseling” as a process measure of the quality of care for acute 
myocardial infarction, congestive heart failure, and pneumonia in 2004. This measure 
includes patients who are given any sort of advice about stopping smoking while they are 
in the hospital. Nationally in 2005 few hospitals reached a goal of 100% compliance to 
the JCAHO smoking cessation measures. Failure of hospitals to comply with evidence 
based medicine is problematic and reflects poorly upon their image. With this in mind, in 
an effort to improve those rates, we proposed a novel study in which we randomized and 
informed California hospitals of their smoking cessation performance and offered to help 
them improve their advice rates. We also let the treatment hospitals know that we would 
publicize their performance in a year in local print media as incentive for the hospitals to 
improve. This component of the study is based on a broader application of protection 
motivation theory, emerging research on how the threat of public health quality reporting 
can stimulate improvement and the push-pull-capacity model of improvement. Over one 
year the control sites had a significantly higher increase in smoking cessation advice 
rates. The end adherence rate was 94% overall (compared to an initial rate of 88%). This 
study demonstrates a secular trend of improvement and the impact collection of JCAHO 
data has on hospital performance in all areas of care, likely via financial incentives.  
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Statement of Issue, Magnitude of Problem 
 
According to the Centers for Disease Control (CDC), cigarette smoking is still the 
leading preventable cause of death in the United States and is responsible for roughly one 
out of every five deaths each year (Centers for Disease Control and Prevention, 2002; 
Centers for Disease Control and Prevention, 2005). Interestingly, it is estimated that more 
deaths are caused each year by tobacco use than by all deaths resulting from human 
immunodeficiency virus (HIV), illegal drug use, alcohol use, motor vehicle injuries, 
suicides, and murders combined (Centers for Disease Control and Prevention, 2002; 
McGinnis & Foege, 1993). Aside from mortality, The CDC’s Morbidity and Mortality 
Weekly Report (MMWR) states that approximately 440,000 people in the United States 
die of a smoking-attributable illness, resulting in 5.6 million years of potential life lost 
and $82 billion in lost productivity from smoking (Centers for Disease Control and 
Prevention, 2002). Furthermore, the CDC estimates that more than 8.6 million people in 
the United States have at least one serious illness caused by smoking, thereby making 
cigarette smoking a continued major reason for hospitalization (National Center for 
Chronic Disease Prevention and Health Promotion, 2008). Finally, for every person who 
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dies of a smoking attributable disease, there are 20 more people suffering with at least 
one serious smoking attributable illness.  
As a result of the extensive health consequences of smoking, it has long been a 
national health issue in the United States. It is of such great interest that the Department 
of the Surgeon General has focused on the topic for over 50 years. The movement started 
in 1957 when Surgeon General Leroy E. Burney declared the official position of the U.S. 
Public Health Service: they determined that evidence pointed to a causal relationship 
between smoking and lung cancer. Soon after in 1961 the American Cancer Society, the 
American Heart Association, the National Tuberculosis Association, and the American 
Public Health Association voiced their concerns to President John F. Kennedy. As a 
result the Kennedy administration took an interest in the issue and in 1962 the then 
recently appointed Surgeon General Luther L. Terry announced that he would convene a 
committee of experts to conduct a comprehensive review of the scientific literature on the 
smoking issue. From 1962 to 1964 this committee reviewed more than 7,000 scientific 
articles with the help of over 150 consultants. They released a report: Smoking and 
Health: Report of the Advisory Committee to the Surgeon General. This report held 
cigarette smoking responsible for a 70 percent increase in the mortality rate of smokers 
over non-smokers, estimated that average smokers had a nine- to ten-fold risk of 
developing lung cancer compared to non-smokers (heavy smokers had at least a twenty 
fold risk) and named smoking as the most important cause of chronic bronchitis, pointing 
to a correlation between smoking and emphysema, and smoking and coronary heart 
disease. Prior to this in 1958, a Gallup Survey conducted found that only 44 percent of 
Americans believed smoking caused cancer; this rose to 78 percent by 1968. Another 
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major action occurred in 1965 when Congress required all cigarette packages distributed 
in the United States to carry a health warning. Finally in 1970 cigarette advertising on 
television and radio was banned (US National Library of Medicine, 2006). The public 
image of smoking is becoming more and more negative and the public expects health 
care communities to take action. 
Since the 1964 report, 30 more reports on tobacco use have originated from the 
Surgeon General, with the most poignant and recent report in 2004. The 2004 Surgeon 
General’s report states that, “As in many areas of public health, there is a need to improve 
the dissemination, adoption, and implementation of effective, evidence-based 
interventions, and to continue to investigate new methods to prevent and reduce tobacco 
use.” (Centers for Disease Control and Prevention, 2005) There is a need for this research 
today at all levels of health. We have seen many public smoking bans and preventative 
measures. Unfortunately public health still lacks in implementation of effective, evidence 
based interventions to help current smokers quit, especially those who are severely 
addicted and smoking the most. Just as all of the historical developments discussed were 
at a national level, there needs to be a national approach using local frameworks. The 
setting of this framework can be in hospitals.  
 
Reasons for Smoking Cessation in the Hospital Setting 
 
Better Outcomes: National policy recommendations recognize the benefit of using 
hospitalization as a teachable moment for tobacco use cessation. While there are an 
abundance of outpatient smoking cessation services available, the prevalence of inpatient 
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programs is fairly limited; there is a gap between the availability of proven interventions 
(discussed later) for tobacco use cessation and their dissemination into the United States 
health care system. This is problematic for two reasons. First, smoking causes coronary 
heart disease (CHD), which is the second leading cause of death in the United States. 
Heart Disease is also the leading diagnosis of hospital inpatients in the United States 
(Hosp Health Netw, 2002). Cigarette smokers are two to four times more likely to 
develop coronary heart disease than nonsmokers, have double the risk of having a stroke 
and are more than 10 times as likely as nonsmokers to develop peripheral vascular 
disease. This is of great importance as cardiovascular related issues are the top reason for 
hospitalization in the United States (DeFrances & Hall, 2007). Since smoking causes 
illness, and those illnesses create the highest hospitalization rate, it is very important to 
reach inpatients who smoke. While the health circumstances are unfortunate, the large 
number of hospitalized smokers offers a perfect setting and situation for quitting, so that 














Figure 1: Smoking/Illness/Hospitalization Cycle 
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Evidence shows that even a single comment from a physician increases the likelihood of 
one quitting smoking (Fiore, 2000). 
Another reason that smoking cessation advice/counseling for inpatients is so 
important is because of the specialized setting of a hospital stay. During a hospital stay, a 
former smoker is a captive audience and does not have the option to smoke due to 
hospital smoking bans (Longo, Brownson, & Kruse, 1995). Furthermore, the patient may 
attribute their illness to smoking, heavily influencing their willingness to quit (Emmons 
& Goldstein, 1992; Munafo, Rigotti, Lancaster, Stead, & Murphy, 2001). The 
psychological impetus to intervene in the hospital combined with the health influences is 
more than enough reason to push for inpatient cessation programs. 
Economic Reasons: Not only are there benefits of inpatient smoking cessation on 
health, but on economic levels as well. The total annual public and private health care 
expenditures caused by smoking was $96.7 billion in 2006, (not including the $4.98 
billion in annual health care expenditures resulting from second-hand smoke). Lost 
productivity due to tobacco use exceeds $97 billion (Centers for Disease Control and 
Prevention, 2007). In terms of cost effectiveness, implementation of the Agency for 
Health Care Policy and Research (AHCPR) guidelines (that all physicians at least offer a 
simple statement that the patient quit smoking at all clinical encounters) would cost $6.3 
billion to implement in its first year. However, society would gain 1.7 million new 
quitters at an average cost of $3779 per quitter, $2587 per life-year saved, and $1915 for 
every Quality Adjusted Life Year (QALY) saved. Compare this to treating mild 
hypertension ($11,300) or hypercholesterolemia ($65,511) for a single patient (Eddy, 
1992). These findings show that smoking cessation interventions in the clinical setting 
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are extremely cost effective (Cromwell, Bartosch, Fiore, Hasselblad, & Baker, 1997). On 
a larger scale, smoking attributable expenditures are at $75,488 million, about 8% of total 
medical expenditures (Warner, Hodgson, & Carroll, 1999). Given that health care is a 
major topic in government spending, reducing tobacco related illness is important for the 
United States economy overall. Therefore, implementation of an effective intervention 
has significant economic advantages both on an individual, hospital and national level. 
The National Commission on Prevention Priorities recently reported that by 
implementing tobacco use screening and interventions into standards of care would save 
as many quality-adjusted life-years as closing existing gaps in the delivery of all other 
adult clinical preventive services recommended by the U.S. Preventive Services Task 
Force combined (M. V. Maciosek et al., 2006a; M. V. Maciosek et al., 2006b). In terms 
of quality improvement, implementation of guidelines increases productivity for hospitals 
and also ratings; it is also in the best interest of the hospital to offer smoking cessation 
advice. 
Guideline requirements: Clearly smoking cessation programs in hospitals benefit 
patients, the hospital and health care. Continuing on the topic of a national setting for 
improvement, the most current national guidelines were issued by The Public Health 
Service in partnership with other organizations including the Robert Wood Johnson 
Foundation, the Agency for Healthcare Research and Quality and the Centers for Disease 
Control and Prevention. These evidence-based practice guidelines released in 2000 
entitled Treating Tobacco Use and Dependence, recommend that every hospitalized 
patient identified as a smoker be offered tobacco dependence treatment. In an effort to 
increase adherence to guidelines, the National Committee for Quality Assurance (NCQA) 
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and Joint Commission on Accreditation of Healthcare Organizations (JCAHO) instituted 
an expansion of performance measures for hospitalized (and other) patients, requiring 
that the tobacco use of all patients admitted to the hospital be assessed and that patients 
interested in quitting be offered tobacco use counseling and pharmacotherapy. The 
United States Department of Health and Human Services and the Institute of Medicine 
have also put forth guidelines and directions for instituting hospital cessation programs 
(National Cancer Policy Board, Institute of Medicine and National Research Council, 
1998). The Agency for Health Care Policy and Research (AHCPR) Smoking Cessation 
Guideline Panel published recommendations that clinicians provide smoking cessation 
services with pharmacotherapy at every clinical encounter with a patient. This 
recommendation was based on a comprehensive and systematic literature review. Finally, 
a Cochrane Review meta-analysis to determine the effectiveness of interventions for 
smoking cessation in hospitalized patients found that intensive intervention (inpatient 
contact plus follow-up for at least one month) was associated with a significantly higher 
quit rate compared to control (Peto Odds Ratio 1.82) (Munafo et al., 2001) thereby 
adding to the widespread base of support. The implementation of these guidelines could 
have large effects on the reach and cessation rates of ill smokers in addition to hospital 
quality.  
 
Example of a Successful Inpatient Smoking Cessation Program 
 
Of greatest interest to this study are JCAHO guidelines. The JCAHO guidelines 
were developed in part because tobacco use cessation programs have been shown to be 
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effective. An example of a successful inpatient smoking cessation program that fully 
meets these guidelines is Staying Free; this program includes a strong message delivered 
by a physician, relapse prevention behavioral-counseling, access to NRT, and follow-up 
calls (Taylor et al., 1996).  The Staying Free program is a part of this research study’s 
methods. 
Theoretical Model: The theoretical model is a blend of social cognitive learning 
theory, transtheoretical stages of change, relapse prevention and nicotine dependence 
models (Taylor, Houston-Miller, Killen, & DeBusk, 1990; Taylor et al., 1996). From a 
social learning theory perspective (Bandura, 1977), an effective smoking cessation 
program should include information about the risks of smoking, the benefits of not 
smoking, the methods of stopping and realistic expectations of outcome, instruction from 
a credible authority (e.g., a physician, nurse or other health care professional) providing 
an unequivocal prescription to stop smoking or not resume smoking, and successful 
performance of the skills important to cope with the personal, behavioral, and 
environmental determinants of smoking. These skills include learning to resist urges to 
smoke in high-risk situations and using nonsmoking strategies to cope with them, 
returning to nonsmoking if relapse occurs, being able to identify changes in strength of 
confidence and identify coping strategies during these times, including social and family 
support.  
The final theory involved in Staying Free is the well known transtheoretical 
model of change or rather, stages of change theory (Prochaska & DiClemente, 1983). 
This theory states that people are in different stages of readiness to change a health 
behavior; as a result, interventions must be tailored to deliver the full benefit. The stages 
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for smoking cessation are below. A smoker must go through the stages in Table 1 (often 
in a non linear fashion): 
 
Table 1: Stages of Change Model in Smoking Cessation 
Pre contemplation Contemplation Preparation Action Maintenance 
The smoker is not 
even considering 
quitting 




The smoker is 
preparing to quit 
in the next 30 
days and is taking 
steps towards that 





for 6 months. 
 
 
The Staying Free program is most appropriate for those in the preparation stage 
where smokers are motivated to quit. For patients hospitalized in the contemplation stage, 
motivational interviewing is applied to move them into the next stage later or reduce the 
amount they smoke, but not the full intervention (Houston Miller & Taylor, 1995). To 
address smoking cessation advice in hospitals in general, hospitalized smokers are more 
likely to be in contemplation or preparation as a result of their illness and situation. Any 
form of the advice is helpful to move them through the stages of change, even if that 
advice is a single sentence.  
Success of Program: Cessation rates with Staying Free patients hospitalized with 
a myocardial infarction were up to 70% at 1 year, compared with 45% to 53% among the 
nontreatment groups. Two follow up studies were also conducted and equally successful 
(Miller, Smith, DeBusk, Sobel, & Taylor, 1997; Taylor et al., 1990). A more recent 
implementation study produced quit rates of 26.3% (Taylor, Miller, Cameron, Fagans, & 
Das, 2005). Therefore, intense programs can be effective; their implementation is 
required. However, even simple systematic advice at the bedside is beneficial. 
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Evidence there is Room for Improvement 
 
Despite all of the research, success, evidence and recommendations put forth, 
evidence shows that enough is not being done in the hospital setting. A meta-analysis of 
33 studies from 1994 to 2006 found that 60% of inpatients in those studies had their 
smoking status assessed and only 42% of patients were advised to quit smoking. The gap 
in the performance AND delivery shows the need for hospital institutional action. 
The most convincing proof of failure to meet evidence based guidelines is also 
provided by JCAHO (Joint Commission on Accreditation of Healthcare Organizations); it 
is one of the regulatory agencies mentioned in the last section. JCAHO recently examined 
their standardized performance measures from 2002 to 2004. They found that among the 
18 measures studied, the most dramatic improvement was observed in the three measures 
of counseling for smoking cessation (Williams, Schmaltz, Morton, Koss, & Loeb, 2005). 
This was a promising indicator, but though there was improvement at individual hospital 
sites, there were still a large number of hospitals not meeting the 100% rate goal, a goal 
that is feasible. While clinical outcomes (like mortality) are difficult to control, process 
measures such as offering smoking cessation advice can be guaranteed to occur. 
Furthermore, while an improvement can be noted, the absolute contact rates for smoking 
cessation advice and counseling are well below the evidence-based benchmark of 100% 
(American Hospital Association, 1991). In 2005, when the last official JCAHO report 
was published, United States hospitals fell short of that goal: 82% advice with acute 
myocardial infarction patients, 66% advice with heart failure patients, and 61% advice 
with pneumonia patients (Williams et al., 2005). 
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JCAHO findings are national and based on heavily research measures. In order to 
develop their performance measures, JCAHO used a thorough process involving a 
content specific technical expert panel, stakeholder input, rigorous testing and 
development of precise technical specifications. All measures were submitted to the 
National Quality Forum (NQF) for review and endorsement. The validity of the measures 
and the accuracy of national collection strengthen the claim that hospitals are actually 
falling short.  
The JCAHO reports are not perfect though. The current conditions may be worse 
than reported estimates in that there may be over reporting of rates. That is, with the 
advent of electronic medical records, healthcare organizations may make it easy to check 
a box that advice has been given. At the veterans administration hospitals for example, 
there is a checkbox system on inpatient intake forms that must be checked for all smokers 
indicating that smoking cessation advice has been given. As a result, the veterans’ 
administration hospitals have 100% advice rates on JCAHO surveys. This may inflate the 
“progress” we see in smoking cessation advice rates.  
Given the widespread health benefits of inpatient smoking cessation 
advice/counseling, more needs to be done to create an even more dramatic change. One 
reason for the low rates of contact may be that the clinician is unable to advise and 
counsel all patients in need due to time constraints, or lack of a systematic 
identification/treatment system in the hospital. Another issue may be that clinicians are 
offering advice, but it is not documented. Other possible reasons for the lack of 100% 
rates currently can be attributed to lack of funds to pay staff, lack of an administrative 
advocate, and difficulty fitting the an actual program into provider goals/routines 
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(O'Loughlin, Renaud, Richard, Gomez, & Paradis, 1998). Policy changes, system 
changes and the need to address quality are added concerns in implementation of 
smoking cessation program (Hollis et al., 2000). 
 
Finding a New Approach to Close the Gap 
 
Regardless of the reason, there is a clear deficit in hospital quality as measured by 
an indicator as simple as smoking cessation advice. Over the last decade, the Institute of 
Medicine has recognized this and other indicators and noted that quality needs to be 
improved in health care in general. The Institute of Medicine released To Err is Human 
(1999) and Crossing the quality chasm (2001), landmark documents trying to answer the 
questions of how to ignite quality improvement. For example, the IOM created new rules 
to improve quality and safety, while driving market share to high-performing providers. 
One of these rules for transformed healthcare system was for there to be transparency of 
performance related information, including information to help patients select health 
plans, clinicians, and hospitals and participate in shared decision-making. This may be 
the solution to closing the quality gap in smoking cessation and will be the basis of this 
study.  
 
Scope of this Research; Justification for Smoking Cessation Research in General 
 
While health care in general needs improvement in all areas, smoking cessation is 
the focus of this study. As mentioned earlier, it has a huge impact on health, has proven 
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solutions and is relatively “easy” to meet guidelines. In addition to these reasons, 
smoking cessation is a quality indicator of interest because there is a need for renewal in 
smoking research. It was the “hot topic” of the public health research community during 
the 1990’s and prior to that. As was noted earlier, it was in the late 1950’s and in 1964 in 
particular that the Surgeon General, Luther Terry, issued the first Surgeon General's 
Report on Smoking and Health. It is true that the research initiated over 40 years has led 
to significant reductions in smoking prevalence. This was so much the case that tobacco 
use reduction has been heralded as one of the top public health successes of all times 
(Centers for Disease Control and Prevention (CDC), 1999a; Centers for Disease Control 
and Prevention (CDC), 1999b).  
More recently there has been a distinct shift in the focus of the health community 
as to what is appealing; obesity is the most fashionable topic today as the rising modern 
day epidemic. With 33% of men and 35% of women in the United States obese, the CDC 
attributes many diseases to obesity including hypertension, osteoarthritis, dyslipidemia, 
type II diabetes, coronary heart disease, stroke and so on. As a result of statistics and 
trends such as these, funding and interest has shifted to obesity. According to Healthy 
People 2010, two of the national health objectives are (1) to reduce the prevalence of 
overweight and obesity among adults to less than 15% and (2) to reduce the prevalence of 
obesity among children and adolescents to less than 5%.  
Furthermore, many entities feel that smoking and smoking related illnesses are 
issues that have been resolved. Obesity researchers refer to the tobacco success as an 
issue of the past and a public health achievement to learn from (Byers & Sedjo, 2007; 
Daynard, 2003; Mercer et al., 2003). It has been argued that the health research 
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community has a (erroneous) tendency to only focus on one major health issue at a given 
time while there should be more synergistic approaches (D. Yach, McKee, Lopez, & 
Novotny, 2005a; D. Yach, McKee, Lopez, & Novotny, 2005b). It is true partially that the 
base of research is well established for smoking cessation so that little methods research 
is needed. It is also true that smoking reduction has advanced in the last forty years. 
However the improvements are still not enough in the areas of program implementation 
and helping current smokers quit.  
Improvement is needed because smoking and tobacco use continues to be a major 
national health issue. A recent MMWR indicated that in 2006, approximately 20.8% of 
U.S. adults were current cigarette smokers. They noted that this rate had not changed 
much since 2004, suggesting a stall in the previous 7-year (1997-2004) decline in 
cigarette smoking among adults in the United States. The MMWR attributes the lack of a 
decline in cigarette use during those years to less funding for comprehensive state 
programs for tobacco control and prevention (decreased by 20.3% from 2002 to 2006) 
(Centers for Disease Control and Prevention, 2002). Both the newest information about 
the smoking decline stall and about those with smoking related conditions indicate that 
the public health research focus shift is premature. To continue Healthy People 2010 
included 27 tobacco related objectives, one of which was the goal of reducing adult 
tobacco use from 24% in 1998 to 12% by 2010 (U.S. Dep. Health Hum. Serv, 2000). 
That time period has almost passed and the smoking rate is only at 20.8%, not to mention 
stagnant. There needs to be more done now and there needs to be renewed interest in 
smoking cessation research/implementation. A place where that improvement is still 
seriously lacking is in the hospital setting (Centers for Disease Control and Prevention 
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(CDC), 1999a; Centers for Disease Control and Prevention (CDC), 1999b). Combining 
emerging concepts of quality improvement in reporting transparency with older, 
established methods of smoking cessation may help create new improvements and may 
serve as a model for other health care quality indicators. This study intends to advance 
smoking cessation research where it is needed most: Inpatient implementation. 
 
A New Approach 
 
The ultimate goal of this study was to encourage improvements by all hospitals in 
California to implement and evaluate their inpatient smoking cessation efforts. We did 
this by dividing all hospitals in the state into control and treatment regions, with 
treatment regions facing publicity of JCAHO smoking cessation data. The concept of 
randomizing a state’s hospitals is a new type of intervention. We are also utilizing public 
reporting quality data in a new way. Creation of JCAHO’s Quality Check helped to 
develop the database in this study. While there still is some JCAHO data processing to do 
in this study, prior to the development of this database one would have to manually 
download individual portable documents for each hospital and extract the data. This is an 
excellent research tool which should be utilized. 
Next, the approach used in this intervention is quite novel: we inform hospitals of 
their performance and forthcoming publicity on the topic while offering a way to improve 
their performance. Quality improvement is at the forefront of organized healthcare and 
smoking cessation advice/counseling at the bedside is a core measure of inpatient quality. 
Not to mention research has led to a vast amount of evidenced based medicine guidelines 
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for it (Fiore, 2000). Optimistically we hope that hospitals are at least encouraging their 
providers to give brief advice to quit smoking at the bedside since that is the bare 
minimum proven to be effective in research (Center for the Advancement of Health, 
2008). The intervention is meant to increase adoption of a specific smoking cessation 
methodology, increase provider training and hospital level practices that promote smoker 
identification and programs. A map of the activities and goals is in Figure 2.  











1a) Hospital  
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Purpose, Research Questions and Hypotheses 
 
The purpose of this study is to test a novel method to increase inpatient smoking 
cessation rates in California hospitals by presenting them with publicity of JCAHO 
performance data.  
Research Question 1 will be part of the Intervention Study in the Methods 
chapter. Research Questions two and three will be a part of the Research Analysis of 
JCAHO Data section in the Methods chapter. 
Research Question 1: Does the threat of public reporting of smoking cessation 
rates affect hospital performance in this area?  
Hypothesis: When faced with public reporting of JCAHO smoking cessation rates in 
local media in a year, treatment hospitals will significantly improve their performance 
compared to control hospitals 
Research Question 2: What factors affect a hospitals smoking cessation rates and 
change in those rates? 
Hypothesis: This is an exploratory analysis intended to find what, if any, hospital 
characteristics are stronger in predicting improvement. Factors include bed size, length of 
stay, revenue and discharges. 
Research Question 3: What effect does the existence of JCAHO performance 
measures have on Hospital Quality (as defined by those measures)? If there is an effect, 
what areas of care are most impacted? 
Hypothesis 3a: Over a two year period, hospitals in California will demonstrate 
improvement in JCAHO smoking cessation advice rates.  
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Hypothesis 3b: Over a two year period, performance on all measures assessed by JCAHO 
will improve. 
Hypothesis 3c: Hospitals will show greater improvements in performance for measures 
that assess process rather than outcome. (Smoking cessation advice is an example of a 
JCAHO process measure.)  







This chapter reviews literature on health care quality and public reporting as a 
means for improving quality.  
 
Conceptual and Theoretical Framework: Public Reporting and Berwick 
 
It was mentioned in the introduction that the IOM is emphasizing transparency 
and reporting of performance to move in a positive quality improvement direction. Dr. 
Berwick, an expert in health care change and quality improvement argues that quality 
improvement leads to change and systems resist change. Therefore, change requires some 
discomfort and tension (Berwick, 2002). Public reporting of performance data can be the 
stressful catalyst of that change. Public reporting does have the potential to improve 
health care quality through remediation where the provider improves in response (Werner 
& Asch, 2005).  
According to Berwick and colleagues’ framework for quality improvement, 
public reporting can lead to performance improvement through two pathways, which are 
interconnected by a provider’s motivation to maintain or increase market share (Berwick, 
2002). These are shown in Figure 2. 







Through selection, patients can compare publicly released performance data and reward 
higher performing providers by choosing them. Through the change (or quality 
improvement) pathway, performance data help providers identify areas in which they 
under perform and improve their performance (Marshall, Shekelle, Leatherman, & 
Brook, 2000). A third pathway of improvement has been proposed: concern for public 
image or reputation (Hibbard, Stockard, & Tusler, 2005a). It has been believed that the 
motivation to change is driven by a desire to protect public reputation or market share. 
Furthermore reports must be widely disseminated to the public and must be easily 
understandable so that the public report can actually motivate improvement. To further 
formalize the theory applied in this study, we refer to protection motivation theory. 
 
Protection Motivation Theory 
 
 
Figure 3: Berwick's framework of quality improvement 
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It was mentioned by Berwick that to produce change there must be discomfort. 
Protection Motivation Theory (PMT) developed by Rogers in 1975 is actually more of an 
individual health behavior theory but can be applied to Berwick’s school of thought. It is 
based on fear appeals and persuasive communication, with an emphasis on the cognitive 
processes mediating behavioral change. The theory was formalized by Rogers in 1983 
based on the work of Lazarus (1966) and Leventhal (1970) (Rogers, 1983). It entails 
adaptive and maladaptive coping with a health threat as a result of two appraisal 
processes: threat appraisal and coping appraisal. An individual considers behavioral 
options to diminish the threat (Boer & Seydel, 1996). The responses can be either 
positive or negative or not present at all (negative). In the case of smoking cessation for 
example, a hospitalized patient may see a threat to their health. They may choose a 
maladaptive response like smoking more because they figure that they have already 
ruined their health. They may choose a positive adaptive strategy like choosing to quit in 
the hospital. Or they may do nothing at all (continue smoking) which is also negative. 
There are four components of PMT that influence actions: 
1) Perceived severity of the threat 
2) Perceived probability the threat will actually occur 
3) The efficacy of the positive preventive behavior 
4) The perceived self efficacy that the individual can adhere to the recommendations. 
In the smoking example, a patient may assess 1) the severity of lung cancer, 2) the chance 
that they will develop cancer, 3) the effect that quitting smoking will have on lung cancer 
and 4) their own efficacy to be smoke free. 
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While PMT is designed for use to alter and study individual health behavior, it is also 
conceivable that PMT can be applied as a theory of organizational change, especially 
with hospitals today. (PMT has been used to study change of individual employee 
behavior in an organization, but not with the organization as the unit of study to date. 
(Welbourne, 1994)) Prior research cited earlier suggests a hospital may receive bad 
publicity, less profit, less shareholder interest and so on as a result of public reporting of 
their quality (if it is bad). As a result, that hospital would either choose act adaptive 
(make positive changes) or not act at all. (It is doubtful they would turn to maladaptive 
behavior). The four areas to consider are 1) the severity of the threat of public reporting, 
2) the chance that public reporting will occur, 3) the usefulness quality improvement may 
have on this and 4) the chances that the organization will be able to implement such 
changes. 
 
Figure 4: Protection Motivation Theory: Source: Rogers, 1983 
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There needs to be motivation to change behavior. It has been thought that 
financial motivation works best. While JCAHO accreditation is not financial, per se, 
performance is related to perception and perception is related to financial gain. This is 
also a reason for the publicity portion of the proposal; by publicizing JCAHO scores, we 
anticipate that hospitals will want to be portrayed favorable since the public perception 
may change their client base. The concept of this motivation is based on fear of financial 
loss (Rubenstein & Pugh, 2006). Motivation can also be the awareness of public image in 
the Berwick model.  
 
Motivation: The importance of partnerships and stakeholders 
 
Partnerships are essential to progress and implementation of evidence based 
medicine. They need to be, “between members of the health services research 
community, such as research funding organizations, academic and educational 
organizations, and scientific journals. They also include partnerships between the health 
services research community and non research-centered organizations, such as those 
concerned with healthcare delivery, community interests, and policy,” as shown in Figure 
5. We, the writers of this proposal, aim to provide the services of the Health Services 
Research Community affecting both hospitals and the public.  
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A way to promote change is to remind hospitals of their stakeholders. “Focusing on 
strategic aspects is important for several reasons. First, EBM is often promoted as a way 
to improve organizational performance, especially in the area of providing legitimate 
services and thus organizational effectiveness. For these reasons, an organization seeking 
to increase its credibility among stakeholders will be motivated to implement EBM 
(Hovmand & Gillespie, 2008). All of these influences/stakeholders motivate change. 
To continue, the goals of improvement at different levels (patient, provider, 
system) are not independent. Linking them together, “arises from our conviction that 
healthcare will not realize its full potential unless change making becomes an intrinsic 
part of everyone’s job, every day, in all parts of the system. Defined in this way, 
improvement involves a substantial shift in our idea of the work of healthcare, a 
challenging task that can benefit from the use of a wide variety of tools and methods.” 
(Batalden & Davidoff, 2007) Quality Improvement is a way of thinking and this shift is 
setting the stage for projects such as the one set forth in this proposal. 
JCAHO’s publication “From Frontline to Front Office” considers organizational 
competition as ways to start change. Health care leaders “are cognizant of their local and 
 
Figure 5: Partnerships and Symbiosis in Improvement (Rubenstein & Pugh, 2006) 
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regional competition, of the trend toward pay-for-performance reimbursement, and of the 
special requirements imposed by outside agencies such as the Joint Commission 
(www.jcaho.org), CMS (www.cms.hhs.gov), and the National Committee for Quality 
Assurance (www.ncqa.org).They are also scanning the environment for powerful 
emerging forces that will shape the industry such as the IOM (www.iom.edu) and their 
special reports on quality and safety, the coming avalanche of gold-standard quality 
metrics promulgated by the NQF (www.qualityforum.org), and the work of high-profile 
health care organizations such as the Institute for Healthcare Improvement (IHI; 
www.ihi.org).” The publication cites, a “diverse collection of accreditors, licensors, and 
regulators create an environment of rules, requirements, and measurements that exert a 
profound shaping effect on health care professionals and organizations.” (Joint 
Commission Resources, 2005) 
In 2003 the Institute of Medicine noted a significant gap between evidence-based 
care and actual practice in hospitals; the report also mentioned the potential benefits for 
the nation’s health and burden if the gap is closed (Adams & Corrigan, 2003). Addressing 
Evidenced Based Medicine and improving health should be the first motivator of change. 
Another motivating factor for health care organizations to implement smoking cessation 
programs is the increase in the patient satisfaction. Studies have found a direct 
relationship between the intensity of smoking cessation services and patient satisfaction 
(Keller, Fiore, Curry, & Orleans, 2005).  
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Push-Pull-Capacity Model: All Encompassing Theory 
 
Much of the change theory described thus far contributes to only one component 
of this study. A model which helps to unite the theories is the “Push-Pull-Capacity” 
model of organizational change. This model was developed by the Robert Wood Johnson 
Foundation and the Center for the Advancement of Health. Developed for tobacco 
cessation research, this theory asserts that the healthcare organization must want to 
change or at least be receptive (pull) while external influences need to help provide 
resources and incentive to improve (push). Before development of this theory, 
dissemination research focused mostly on push without acknowledging pull (the 
stakeholders) (C. T. Orleans, Gruman, & Anderson, 1999; C. T. Orleans, 2003)(Green et 
al., 2006). A graphical representation of the model is in Figure 6 (Curry, 2000). Using 
this diagram, we have the same goal of increasing the adoption, reach and impact of 
smoking cessation evidence based guidelines. The push is based on that evidence that 
there are proven inpatient smoking cessation programs (France, Glasgow, & Marcus, 
2001; Rigotti, Munafo, Murphy, & Stead, 2003; Smith, Reilly, Miller, DeBusk, & Taylor, 
2004). The market pull is portion of the model that had previously been ignored; it is the 
incentive to change. Using Berwick theory, public reporting and publicity is a pull for 
health care to change. Finally the capacity component is what we hope to help healthcare 
organizations develop: By offering free training to implement smoking cessation 
methods, we offer those resources to individually counsel organizations so that they can 
implement based on their infrastructure.   
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Figure 6: Push-Pull-Capacity Theory 
 
 
Flaws in Public Reporting Framework 
 
There are a few flaws in the emerging conceptual framework of quality 
improvement and public reporting. First, currently the public rarely seeks performance 
data (Hibbard, Stockard, & Tusler, 2005a; Hibbard, Stockard, & Tusler, 2005b). This 
may be due to lack of interest or difficulty in understanding. Another issue is access. Our 
strategy intends to make the public easily aware of hospital performance by publishing 
the quality results in the local general newspapers. Few health consumers likely check 
sites such as a performance website, but do likely refer to their local newspaper on a daily 
basis. We also are utilizing JCAHO quality data, which is well researched and user 
friendly.  
In a recent study critiquing public reporting as a means for change, the authors 
found three key elements for success in the realm of public reporting to enhance hospital 
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improvement. The first is the need to disseminate information. The second is the need for 
consistency and finally the third is for evaluation (Hibbard, Stockard, & Tusler, 2005a). 
Luckily the JCAHO performance reports are consistent and continually evaluated. What 
is lacking is dissemination. However with the easy accessibility of the reports online, 
dissemination has strong potential, especially if the public is made more aware through 
media. 
Another reason previously cited for why processes and outcomes may be slow to 
change is the inability to switch providers because constraints related to insurance or 
travel (Schneider & Lieberman, 2001). While public reporting is available for the 
healthcare consumer, how likely is it that they will actually act upon the information they 
learn? An underlying assumption in the literature is that consumer choice is required for 
public reporting to stimulate quality improvement among plans and providers (Marshall 
et al., 2000). However, this is not necessarily needed. Consumer choice is important but 
public image has a large effect as well (Hibbard, Stockard, & Tusler, 2005b). While this 
is something to consider in designing a study that tries to measure the impact of public 
reporting, it is important to acknowledge the role that the healthcare organization has in 
the process. In this study it will be proposed that we assess hospital responses to public 
reporting, rather than the consumer response. While the consumer may face constraints in 
their health care choices, the hospitals should still try to improve already to increase 
performance and overall market share, perhaps as dictated by insurance. It is also thought 
that patients have interest in a hospital or provider recommended to them by their 
provider or close associates. As a result of this, quality and image do matter as they 
influence advice provided to patients.  
  29 
Another problematic thought is that consumers are unaware of the differences in 
hospital quality. In a survey of consumers, 60% of respondents thought that hospitals do 
not differ in safety or quality (Berwick, James, & Coye, 2003). Consumers define quality 
medical care differently from experts and industry leaders; and most often attribute 
quality of care to access, cost, having a choice of physicians and position qualifications 
(Hibbard, Stockard, & Tusler, 2005b). Consumers need to be made more aware. 
There is also confusion at the hospital level. In a study among several hospital 
administrators and leaders in California, it was found that they doubted publicly released 
comparative data because a belief that they lacked legitimacy. However the concept of 
public report did tend to lead to action. Furthermore it was found that what gets measured 
gets attention (Davies, 2001). Therefore in choosing a measure of interest, it must be 
legitimate and worthy. Health care administrators take JCAHO very seriously and based 
on all of the evidence, smoking cessation advice is a worthy measure. 
The next flaw is that it has been argued that public reporting may be a destructive 
approach to improving quality, causing antagonism, removal of services and other 
consequences. Some suggest public reporting to providers only, but also comment that 
such an approach might warrant distrust from the public. The best strategy balances the 
dilemma of public reporting by allowing hospitals time to improve performance before 
public reports are easily accessible to the public. Referring to Figure 5, the antagonism is 
reduced by offering a partnership. 
Finally there is also concern that little research has been done in this field. A 
major criticism in the literature is that little research actually examines the effect of 
public reporting on the delivery of healthcare. We hope to change this. The public release 
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of performance data has been proposed as a mechanism for improving quality of care via 
transparency and greater accountability of health care providers (Lansky, 2002). Prior to 
this decade, the role of public reporting on quality improvement was unclear. In 2000, 
Marshall, et al performed a systematic review on the use and impact of publicly released 
performance data and found that data were limited but that hospitals responded to data 
(Marshall et al., 2000). A similar 2001 systematic review concluded that publicly 
reported performance data did not  meaningfully affect decision making, quality 
improvement activity, or competition (Schauffler & Mordavsky, 2001).  The most recent 
review in 2008, included 45 articles published since 1986 that evaluated the impact of 
public reporting on quality. They found that evidence is scant, particularly about 
individual providers and practices that rigorous evaluation of many major public 
reporting systems is lacking but that overall evidence suggests that publicly releasing 
performance data stimulates quality improvement activity at the hospital level. 
Unfortunately the authors comment that most of the studies included in their review were 
small, limited in reliability and used the same non-national quality reporting measures 
(Fung, Lim, Mattke, Damberg, & Shekelle, 2008). 
 
Gap between evidence and implementation 
 
While there is a large evidence base and many recommendations surfacing in the 
literature, there is still a gap in the step of implementation of EBM. This was described in 
the introduction and will be expanded upon here. Translation has been emphasized by the 
IOM, yet scientists have been “slow to realize” methods to actually implement 
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(Rubenstein & Pugh, 2006). Initially, EBM was meant to help individual clinicians make 
better evidence-based decisions. Seeing the potential of this approach for closing the 
evidence–practice gap, various organizations including many specialty societies, the 
Cochrane collaboration and Agency for Healthcare Research and Quality (AHRQ) have 
also used EBM techniques to inform their audiences. The resultant products—systematic 
reviews and practice guidelines—are made available to a group of physicians to aid them 
in making evidenced-based decisions for their patients. More recently, the focus has 
shifted from the individual to the organization. This is likely due to the provider burden. 
While there are many individuals providing smoking cessation at the bedside, it may not 
be done systematically or completely. This is not a necessarily a reflection of the 
provider; they may have too many responsibilities and not enough time as a result of 
stringent healthcare. Ironically, it would be beneficial to these systems to provide 
counseling to patients to decrease costs in the future and make the physician encounter 
simpler; a patient that does not smoke has fewer comorbidities.) Therefore there is a 
conflict between physician burden caused by the organization and the organization 
needing this service as showing in Figure 7. For this reason, it would be best have a 
systematic built in method of smoking cessation advice, a formal program. Making 










The reason for lack of implementation has long been blamed on organizational factors 
and the potential for disruption. Improvement requires disruption and may initially result 
in decline in performance. “On the surface, it seems reasonable to expect better 
interventions to yield better performance. However, experience and theory show that this 
does not always happen. Effective implementation often demands changes in resource 
flows, processes, and sometimes values. When implementation disrupts the very features 
of an organization that made it successful, organizational performance can decline.” This 
is why hospitals may resist change (Joint Commission Resources, 2005) and any 
improvement efforts should allow a hospital to change at their own pace and within 





















Figure 7: The conflict between organizational rules, physician burden and quality 
  33 
Public Reporting, Quality and JCAHO Quality Check 
 
In order to properly mark quality improvement, measures are required (Nelson et 
al., 2000). Health care quality is difficult to measure. However, with the definition of 
“better practices,” organizations such as the AHRQ (Agency for Healthcare Research and 
Quality) find that quality improvement is now more tangible. Furthermore, they suggest 
that quality indicators can be divided into input counts (structure and process) and output 
(outcomes). Unfortunately measuring quality presents a whole new burden. As a result, 
the IOM and other national organizations set forth to find out how to better measure 
quality in hospitals (Institute of Medicine, 2000). 
In 1999, following the Institute of Medicine’s (IOM) National Roundtable 
Discussions and the publication of Crossing the Quality Chasm (Institute of Medicine, 
2001) healthcare quality grew to be of great interest. It became clear that the quality of 
health care is variable and often inadequate (Jencks, Huff, & Cuerdon, 2003). As a result, 
initiatives to measure quality data grew including those documented by JCAHO. Until 
recently, there was no national database of healthcare quality; the Centers for Medicare 
and Medicaid Services (CMS), the Joint Commission on Accreditation of Healthcare 
Organizations (JCAHO), the American Hospital Association, and consumer groups such 
as the American Association of Retired Persons, initiated an effort now called the 
Hospital Quality Alliance (HQA) The initial database focused on acute myocardial 
infarction, congestive heart failure, and pneumonia. Data became available on the 
Internet in late 2003 for the CMS (at www.cms.hhs.gov) and in July 2004 for JCAHO (at 
www.qualitycheck.org).  
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A national landmark in hospital quality measurement occurred in 2002, when 
JCAHO implemented improved performance measures in their accreditation process for 
over 3000 hospitals. Furthermore, as part of the new accreditation process, JCAHO 
instituted “Quality Check” in 2004, a web-based resource that provides Hospital Quality 
Reports for the public and health care professionals. In Quality Check, hospitals’ results 
are compared to the results of all Joint Commission accredited hospitals using 
performance symbols; scores range from minus, check, plus and star. JCAHO specified 
“smoking cessation advice and counseling” as a process measure of the quality of care for 
acute myocardial infarction, congestive heart failure, and pneumonia. This measure 
includes patients who are given any sort of advice about stopping smoking while they are 
in the hospital. JCAHO reports the percent of eligible patients (smokers) receiving advice 
and/or counseling to quit smoking. 
 
Useful Definitions and Acronyms 
 
• Benchmark: Attribute or achievement that serves as a standard for other providers 
or institutions to emulate.  According to JCAHO, the benchmark for smoking 
cessation advice is 100%.  
• CDC: Centers for Disease Control is a federal agency in the Department of Health 
and Human Services; they investigate and try to control or prevent diseases  
• Composite smoking cessation rate: In this study we use a composite smoking 
cessation rate (see Figure 9) instead of individual measure set rates. Heart Attack, 
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Heart Failure and Pneumonia each have a smoking cessation score. We use a 
composite of this score in data reporting to make the report more straightforward.  
• EBM: Evidence-Based Medicine refers to the portion of the practice of medicine 
that is based upon established scientific findings as derived from clinical research 
studies. EBM leads to the development of clinical guidelines, protocols, and care 
paths. 
• Final Rate: The JCAHO smoking cessation advice rate for a hospital or region 
one year after letters were sent out in the intervention.  
• GLM: Generalized Linear Model 
• Individual Measures: Refers to individual measures used by JCAHO such as 
smoking cessation advice rate. This is not to be confused with “measure set.” 
Table 12 further clarifies this. 
• Initial rate: The JCAHO smoking cessation advice rate for a hospital or region at 
the time letters are sent out in the intervention.  
• IOM: The Institute of Medicine’s goal is to improve the nation’s health care. It 
was established in 1970 under the charter of the National Academy of Sciences. 
They provide independent, objective, evidence-based advice to policymakers, 
health professionals, the private sector, and the public. Their most notable 
publications are: To Err is Human (1999), and Crossing the Quality Chasm 
(2001).  
• Measure Set: Refers to sets of quality measures JCAHO has in place. This study 
focuses on three sets: Heart Attack, Heart Failure and Pneumonia. This is not to 
be confused with “individual measures.” Table 12 further clarifies this. 
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• Quality Check: Quality Check is JCAHO’s search engine to locate health care 
organizations in the United States. 
http://www.qualitycheck.org/consumer/searchQCR.aspx 
• Smoking Cessation Advice Rate: This is the measure used by JCAHO. In order to 
fulfill this, a provider must simple offer a sentence of advice to a smoker to quit 
smoking.  







Overview of Methods 
 
In order to address the issues presented in the introduction with the emerging 
frameworks from the previous chapter, methods described in this chapter were 
completed. The following is a brief summary of the methods and will be elaborated upon 
in the remainder of the chapter. 
I. Intervention methods (Research Question 1): To affect change on the state 
level to motivate hospitals to be more aware of their smoking cessation rates 
and services  
A. Activity 1: Randomize all hospitals in California to treatment and control 
regions 
B. Activity 2: Inform treatment hospitals of their current JCAHO smoking 
cessation advice rates and researcher intention to publicize these rates in 
local media; offer smoking cessation training at cost to treatment (then 
control) hospitals  
C. Activity 3: Reassess smoking cessation rates to determine if the 
intervention had an effect 
D. Activity 4: Complete post analysis to determine predictors of greater 
improvement. 
II. Research Analysis of JCAHO Data (Research Questions 2 and 3): Summarize 
JCAHO trends of smoking cessation rates in the context of other measures 
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A. Activity 1: Collect and organize JCAHO data on smoking cessation and 
all other measures in heart failure, heart attack and pneumonia care for all 
California hospitals 
B. Activity 2: Collect and compile other baseline information on hospitals 
such as size, revenue and volume 
C. Activity 3: Map trends of smoking cessation advice over two years to 
identify which hospitals are lacking and regress advice rates on hospital 
characteristics/areas 
D. Activity 4: Comment on JCAHO data trends, where improvement is 
occurring and where it has most potential. 
 
 
Intervention Study: Recruitment and Randomization 
 
This purpose of this section was to test a novel method to increase inpatient 
smoking cessation rates in California hospitals by presenting them with publicity of 
JCAHO performance data. We began planning this portion of the study by dividing 
California into geographic regions and matching the regions on the basis of number of 
hospitals, population size, ethnic background, median income and percent smokers. A 
map of the regions is in Figure 8. We chose to divide the state into regions to simplify the 
study and also because the intended publicity of performance was going to be through 
regional print media. Divisions were based on natural borders and zoning from California 
Government websites. Once the zip codes for each region were established, we could use 






Once the regions were paired we randomized each member of the pair into a treatment 
and control group using a random number generator.  
 
Intervention Study: Creation of the database 
 
We constructed a JCAHO database of smoking cessation counseling/advice 
results for all hospitals in  California in the areas of care of heart attack, heart failure and 
pneumonia. JCAHO quality reports are published quarterly on 
http://www.qualitycheck.org. The data are published with quarterly and yearly results, 
but there is a six month delay on release of information in order for JCAHO to compile 
results. Therefore data downloaded today may reflect hospital performance from 6 to 9 
 
Figure 8: Division of California into Geographic Regions 
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months ago. Information gathered from Quality Check for each hospital includes the 
number of patient records assessed and the percent counseled/given advice to quit 
smoking among the three diagnosis groups. If we refer to the sample data in Figure 9, we 
see for hospital A that JCAHO provides the proportion in each diagnosis group contacted 
and the number of eligible patients. From this information we calculated an overall 
advice rate by dividing the calculated total number of patients counseled by those that 
were eligible across the three diagnoses. So for hospital A, 47 contacted of 76 patients is 
62% contacted. 
 
Figure 9: Calculation of Average Rate 









Hospital A MI 0.44 34  15  
Hospital A HF 0.83 24  20  
Hospital A Pn 0.67 18  12  
       
     Total Eligible= 76 
     Total Contact 47 
     
Overall contact rate=Total 
Contact/Total Eligible 0.62 
 
 
Intervention Study: Research Procedures and Intervention 
 
Treatment: Those hospitals in the treatment regions were intervened upon in the 
following manner. We identified a few key individuals at each organization that would be 
concerned with quality, smoking cessation or overall hospital performance. Examples 
included the Chief Executive Officers, Medical Directors and the Chairman of the Board. 
We also identified a couple of other key individuals such as the Director of Health 
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Promotion or Quality Improvement. Contact information was gathered by calling each 
hospital and extensive web searches. Using the data from Quality Check (previous 
section), a letter was constructed to notify the organizations of their performance in 
JCAHO’s Quality Check. The letter outlines the goals of our group in trying to improve 
smoking cessation services nationally. In addition, we supplied a graph with the 
organization’s performance in comparison to national averages. The letter closes with 
plans for publishing the region’s hospitals’ results in the local media. A copy of the letter 
is provided in Figure 10. Letters were sent to roughly 240 hospital administrators and/or 
health care staff in the treatment regions from Figure 8. 
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Figure 10: Sample letter sent to hospitals 
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Hospitals were also offered an opportunity to improve their smoking cessation 
contact values during the 12-month period between the initial letter and publication of 
latest JCAHO data in local print media. Training was available (at cost to cover 
materials) to instruct hospitals and provide resources to implement a hospital wide 
smoking cessation program. Attendees were given a copy of the recent book 
“Implementing an Inpatient Smoking Cessation Program” and access to our website as a 
continued resource. Examples of the training flyer and website screenshot are in Figure 
11. The workshop training for health care professionals in Staying Free consists of both 
intervention methods and implementation methods. The six hour course includes: 
didactic information around smoking cessation and success of randomized controlled 
trials, and skill building directed at implementation of the Staying Free intervention that 
includes how to deliver an appropriate message, take a smoking history and provide 
behavioral counseling and pharmacotherapy, undertake telephone follow-up.  Following 
the presentation of the didactic components (overview of smoking, implementation of 
Staying Free Intervention), health care professionals watch a videotape of a bedside 
counseling sessions conducted by the creators of Staying Free. Health care professionals 
role-play three scenarios in dyads.  All trainees are given supporting materials in the form 
of check-off lists and scripts to help them master skills associated with counseling.  Next, 
the training emphasizes implementation techniques that have been successful in the past. 
The final 30 minutes are devoted to responding to questions and issues that were not 
previously understood or addressed by the trainer. This training has been evaluated and 
shown efficacious (Cameron et al., 2002). 
  44 
It was important to consider the issue of antagonism described in the previous 
chapter. While fear is essential to protection motivation theory, it is important that we 
maintain our roles as a partner and resource. This was one of the reasons for the delay in 
publicity; we wanted to offer help and not just a threat to improve. This is also why we 
offer training at cost and free resources on the website. The second reason for the delay is 
a method based reason: we were measuring the effect of the letter on hospital quality. 
There needed to be a 1 year lag to allow for improvement and at least 6 months worth of 
posting of post-letter data on QualityCheck. 
 







Figure 11: Training materials and resources offered 
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Control group: No effort was made to contact the control groups. However, after 
the project, given funding, we hope to offer the training to all control hospitals at cost as 
well. 
Intervention Advertisements: About one year after the letters were sent, a 
widespread publication was selected in each of the treatment regions. A news release was 
constructed and posted, consisting of a brief explanation of JCAHO’s quality measures, 
their goal of 100% contact for tobacco use cessation counseling/advice and the percent 
(with n) of eligible patients provided with smoking cessation advice/counseling in the 
local hospitals. Media outlets were determined by web searches for the most popular 





Figure 12: Sample Advertisement 
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We aimed to have this advertisement appear as a health awareness ad for the local 
community, stakeholders and hospital.  
 
Intervention Study: Construction of the follow-up database 
 
The database was updated to reflect follow up data from Quality Check. Because 
of the 6 month lag, we could construct the database 18 months after the letters were sent. 
This way we gave the hospitals had a total of one year to improve. This was all done with 
the cooperation of JCAHO; they have been instrumental in providing us with all of their 
archived data. The raw data was processed and transformed to reflect composite smoking 
cessation rates (Figure 9), change rates from the initial time period, intervention groups 
and region. We also added in data from the American Hospital Database on bed size, 
length of stay, revenue and discharges.  
 
Intervention Study: Data Analysis 
 
Specific data analysis will be described in the results section. In general though, 
we compared initial JCAHO scores to final scores. We then assessed whether the change 
varied by intervention group. Finally we modeled change in scores by hospital 
characteristics to determine if there are any successful predictors. If this novel method of 
change has an effect, it can be applied to other areas of healthcare. If it does not work, we 
can reevaluate it as a quality improvement tool. 
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Research Analysis of JCAHO Data: Purpose 
 
Quality improvement is still an emerging field in healthcare research. While there 
is an abundance of data, we still do not have evidence where improvements are occurring. 
There are a number of studies that have shown that hospital quality is improving overall, 
but specific information about the measures is not yet published. Aside from the cited 
2004 paper, little has been done with JCAHO QualityCheck. Using smoking cessation as 
a point of comparison, we seek to map JCAHO quality measures over the time period of 
the intervention time (for consistency).  
 
Research Analysis of JCAHO Data: Research Procedures 
 
The intended methods were as follows: We first compiled data over two years in 
quarterly form from the JCAHO website for all California hospitals. This data includes 
JCAHO contact rates for all individual measures in the three measure sets (heart attack, 
heart failure and pneumonia). In addition to the JCAHO data, we also gathered other 
information from the American Hospital Database that includes organization bedsize, 
revenue, length of stay and discharges. 
Analysis will be further described in the results sections. In general we aimed to 
look at JCAHO trends as a result of reporting and also comment on what determines 
more quality improvement. More specifically, we sought to analyze and report the 
following: 
o Descriptive information to characterize overall quality rates. 
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o Model rates and trends by initial rate, bedsize, discharges, length of stay and 
revenue 
The goal of the analysis was to anticipate which sets of measures, individual 
measures and hospital characteristics show improvement and which are in most need of 
improvement. 
 






Intervention Study: Initial Pairing of Regions 
The characteristics of the pairs of region can be seen in Table 2. The regions were 
first made using geographical boundaries. Once each region was defined, their composite 
population and area statistics were compiled using census data. A spreadsheet was used 
to detect differences between every combination of regions and the pairing with the 
smallest differences was chosen. The last two pairs of regions are problematic because 
they are so few hospitals. Complete JCAHO data at the initiation of the study was not 
available on all hospitals so regions that have fewer hospitals had more of a chance of 
being excluded from comparison for insufficient data. Also, these sparsely populated 
areas may have hospitals not yet equipped with the technology/infrastructure for 





































A SF Bay Area 7039362 97 59 20 7 18 9 50 36.42 255715.8 7 60604.6 15 91 
 Southland1 9519338 99 49 45 10 12 24 49 32 3133774 16 42045 16 113 
B Southland2 3599486 99 66 31 2 12 15 50 33.75 589260.5 9 56409 14 45 
 San Diego  2956194 96 66 29 6 9 14 50 32.1 517030.5 11 40007 15 28 
C SacramentoMetro 1936006 90 70 16 7 9 7 49 34.3667 118811 12 44737.7 18 20 
 Southland3 3254821 94 62 38 8 4 20 50 31.7 517406 14 42254 20 38 
D South Coast  1762669 89 66 37 4 4 20 51 32.88 115026.8 14 45823.2 17 28 
 S San Joaquin  1419998 84 56 46 5 6 27 51 30.5 108474.5 21 34288.8 20 27 
E N Sacramento  467723 71 85 12 1 2 6 49 35.54 35854.8 16 33294.6 20 14 
 N San Joaquin  1221149 89 62 34 5 8 18 50 30.8667 130196.67 16 38387 19 19 
F Oregon Border 81257 46 84 10 2 2 3 51 40.4 10503.333 17 29871.3 20 5 
 North Coast  284114 59 84 10 1 1 5 50 40.625 28516.25 15 31756.3 20 11 
G Sierra Nevada  150240 46 90 8 2 1 2 53 41.4 14259.75 10 40032.5 18 8 
 Nevada Border 179291 37 88 9 2 1 4 52 41.6 10024 11 39783 18 9 
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Intervention Study: Response to Intervention 
 
 Among the intervention hospitals contacted (115 total), 3 hospitals registered and 
1 other hospital heard about the workshops and requested attendance. Participants were 
highly satisfied with the course. The initial feedback suggested that we need to focus the 
training more on helping with program implementation and not on providing counseling 
unless requested as a separate workshop. 
 
Intervention Study: Improvement at Each Hospital 
 
 Data for the quarter that the letters were sent out will be referred to as “Initial 
Rate” and data after one year, as specified in the letter will be referred to as “Final Rate.” 
(These are actually Quarter 3 of 2006 and 2007 respectively.) The reason these dates 
were used was because we wanted to measure the effect of the intervention. All hospitals 
received their letters in mid 2006; therefore this is the initial rate. 
 To determine if there was an improvement at each individual site in California, a 
paired t test using initial and final rates, for all hospitals, then for control and intervention 
hospitals was completed. The results are in Table 3 and only include hospitals with data 
at both time points.  
 
Table 3: Initial and Final Smoking Cessation Advice Rates 
Group Mean Initial Rate (sd) Mean Final Rate (sd) t df p 
All (n=245) 88% (18%) 94% (11%) 6.11 244 P<0.001 
Control (n=139) 86% (19%) 94% (12%) 5.91 138 P<0.001 
Intervention (n=106) 90% (14%) 94% (11%) 2.56 105 P=0.012 
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 There is a statistically significant difference between initial and final rates for all 
hospitals and by treatment group. The effect is slightly less for the intervention group, 
likely because their initial rates were so high, so there was less room for improvement.  
  
Intervention Study: Improvement by Treatment Group 
 
 We had difference data available on 139 control hospitals and 106 treatment 
region hospitals as shown in Table 3. Table 4 summarizes the baseline and follow-up 
JCAHO data. Note that the smoking cessation rate reflected is the composite across heart 
attack, heart failure and pneumonia care. For Pair G, there was insufficient data and too 
few hospitals to present a comparison. All analyses were completed at the α=0.05 level 
using SPSS software. These comparisons were done using independent paired t tests.  
(The following assumptions were tested and met: groups were approximately of the same 
size, observations were independent. Because the initial rates were not of comparable 
mean and variance, we focus on change in rates through this analysis.) 
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Table 4: Initial Rates and Change in Rates 
 Baseline Rates Change in rates 





















Pair A 67 83% (21%) 53 90% (15%) 0.038* 66 10% (2%) 51 4% (1%) 0.083 
Pair B 28 86% (24%) 19 91% (14%) 0.326 26 16% (11%) 17 4% (18%) 0.951 
Pair C 23 88% (15%) 16 94% (12%) 0.212 23 7% (11%) 15 6% (11%) 0.765 
Pair D 17 81% (27%) 11 87% (13%) 0.443 16 12% (27%) 9 0% (21%) 0.217 
Pair E 5 97% (4%) 12 92% (10%) 0.119 5 0% (4%) 12 6% (9%) 0.070 
Pair F 2 80% (10%) 3 89% (19%) 0.558 2 12% (21%) 2 -3% (5%) 0.486 
Pair G -- -- -- -- -- -- -- -- -- -- 
All pairs 143 84% (21%) 115 90% (14%) 0.012* 139 8% (17%) 106 4% (16%) 0.047* 
* p<0.05%
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 The baseline smoking cessation advice data were not comparable for the 
intervention and control hospitals based on the sixth column of the last row of Table 4 
(t(250)=-2.53, p=0.012). However, when separated by region pairs, it is apparent that the 
difference is mainly attributable to Pair A (p=0.038). While we tried to initially match 
regions based on several characteristics in Table 2 the smoking cessation baseline data 
were not available until 6 months after randomization due to the lag in JCAHO data. The 
baseline differences are problematic since the control hospitals had a significantly lower 
initial rate. Therefore in order to account for the baseline dissimilarities, we used the 
change in cessation advice rates as the outcome measure (right columns). There were no 
significant differences between the intervention and control hospitals in comparing the 
change in cessation rates on a region by region basis, but in combining the regions there 
was a significant difference in change values t(243)=2.00, p=0.047. An ANOVA was 
also completed to test the effect of region and the interaction term of region and 
intervention; here were no significant differences in change. Interestingly the direction of 
the significance is such that the control hospitals improved more in rates than the 
treatment hospitals (8% improvement versus 4% improvement). It is important to note 
control hospitals had lower initial rates. Since rates max out at 100%, the control 
hospitals had more room to improve. Therefore, the following analysis was completed. 
 
Intervention Study: Comparing Initial and Final Rates by Mean Cohorts 
 
Another analysis was done to measure the change in hospitals at or below the 
mean baseline advice rates and those above separately. The results are shown in Table 5.  
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Table 5: Rates by Mean Cohort 
 Initial Advice rate % (sd) Final Advice rate % (sd) Significant difference 
All hospitals (n=245) 88% (17%) 94% (11%) P<0.001 
Hospitals at or below mean 
baseline rate (n=68) 
65% (18%) 89% (16%) P<0.001 
Hospitals above mean 
baseline rate  (n=177) 
96% (5%) 96% (1%) P=.803 
  
Hospitals at or below the initial rate average had a significant change in rates, 
while hospitals who were higher performing initially did not improve at all. This 
demonstrates the logical finding that hospitals with more room to improve did in fact 
improve more than those already performing well (one sided t test also had p<0.001).  
 
Intervention Study: Changes by Area of Care 
 
It was also of interest to assess whether the changes in rates by intervention were 
different for the three areas of care. Table 6 summarizes this information.  
Table 6: Rates by Area of Care and Treatment 
Area Control  
Mean rate (sd) 
Intervention 
Mean rate (sd) 
Significant 
Difference? 
All Areas 8% (17%) 4% (16%) 0.047 
Heart Attack 4% (11%) 3% (15%) 0.853 
Heart Failure 5% (17%) 2% (17%) 0.141 
Pneumonia 12% (22%) 7% (21%) 0.125 
 
While the composite rate difference was significant based on treatment, there were no 
differences in individual areas of care. 
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Intervention Study: Hospitals Participating in the Training 
 
Four hospitals elected to participate in the training. Due to the small number, their 
descriptive rate data will be provided in Table 7: 
Table 7: Descriptive Data of Participating Hospitals 
Hospital Initial Rate Final Rate 
HMO 77% 93% 
Private Hospital 100% 100% 
Private Hospital 100% 100% 
University Hospital 90% 96% 
 
Due to small sample size, statistical comparisons were not made among participating 
hospitals. 
 
Intervention Study and Research Analysis of JCAHO Data: Regression of change based 
on other hospital characteristics 
 
The American Hospital Database (AHD) contains valid data on staffed beds, 
discharges, patient days and total revenue for 159 hospitals in California. Using this 
information and also the initial baseline advice rates and intervention category, multiple 
regression was conducted to predict change in scores. (Assumptions of linearity, 
normally distributed errors, and uncorrelated errors were checked and met. There was 
some evidence of colinearity of AHD data.) The means, standard deviations and inter 
correlations are in Table 8.  
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Change in rate 0.04 0.16 -0.07 -0.78** -0.13* -0.17* -0.07 -0.24* -0.13* 
Patients Eligible for Advice at Baseline 27.26 19.46 - 0.13* 0.12 0.55** 0.58** -.12 0.40** 
Composite Baseline Rate 0.89 0.16  - 0.06 0.13 0.14* -.04 0.20** 
Intervention? 0.40 0.49   - 0.00 -0.05 0.12 0.13* 
Staffed Beds (x100) 2.79 1.63    - 0.88** 0.14* 0.77** 
Total Discharges (x 1000) 12.49 8.17     - -0.14* 0.79** 
Average length of stay 5.92 4.04      - 0.81** 




The combination of variables significantly predicted the change in rates F(7, 
151)=49.56, p<0.011. The adjusted R squared is 0.68 indicating that over 2/3 of the 
variance in the change in rates was explained by the model. The beta weights in Table 9 
indicate that the strongest predictors of the change in rates were the composite baseline 
rate and total discharges. 
 
Table 9: Coefficients for Hospital Characteristics in predicting change 
 B Std. Error Beta 
Patients Eligible for Advice at Baseline 0.001 0.00 0.05 
Composite Baseline Rate -0.807 0.05 -0.80** 
Intervention? -0.022 0.02 -0.07 
Staffed Beds (x 100) -0.021 0.01 -0.22 
Total Discharges (x 1000) 0.002 0.00 0-.08 
Average length of stay -0.008 0.00 -0.21** 
Gross Patient Revenue (x 100,000) 0.002 0.00 0.11 
*<0.05; **p<0.01 
 
Research Analysis of JCAHO Data: All JCAHO Measures in Heart Attack, Heart Failure 
and Pneumonia 
 
The repeated measure ANOVA of the quarterly rates for the two years included in 
the main analysis was completed with a Greenhouse-Geissner correction to assess if there 
was a difference in rates over time by measure set and individual measures. This is 
similar to the JCAHO study in 2005 (Williams et al., 2005). (The following assumptions 
were tested: independence of observations, normality and sphericity. The last assumption 
was violated, warranting use of Greenhouse-Geissner corrections.) Between subjects 
comparison of the trends were based on measure sets and individual measures listings. 
We also used hospital characteristics to create models and divided each measure into two 
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groups. For example, for staffed beds, we made two categories: those below the mean 
number of bed and those above. Splitting the groups into two helped to make logical 
comparisons, especially in the graphs below. Splitting them further would run the risk of 
multiple comparisons and false results.  
Results indicated that rates changed over the 8 quarter period, in general, by 
measure set, by individual measure and by hospital characteristics. These results are 
reflected in Table 10: 
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Table 10: Repeated GLM ANOVA statistics 
Between Subjects F value p value Significant Linear trend? 
None (Overall rates) F(5.06, 16873.96)= 250 P<0.001 F(1, 3334)=728.44; p<0.001 
Measure Set F(14, 3320)= 165 P<0.001 F(2, 3332)= 58.55; p<0.001 
Individual Measure F(2, 3332)= 134 P<0.001 F(14, 3320)= 44.52; p<0.001 
Staffed Beds (2 categories: above and below average) F(1, 2508)= 13.65 P<0.001 F(1, 2508)= 4.37; p=0.037 
Total Discharges (2 categories: above and below average) F(1, 2508)= 24 P<0.001 F(1, 2508)= 6.52; p=0.11 
Length of Stay (2 categories: above and below average) F(1, 2508)= 30 P<0.001 F(1, 2508)= 0.59; p=0.44 
Gross Patient Revenue (2 categories: above and below average) F(1, 2222)= 52 P<0.001 F(1, 2222)= 6.59; p=0.01 
 62 
The mean and standard deviation of the 8 quarter values (all measures, first row in 
Table 10) are in Table 11.  
 
Table 11: Means and SDs of all rates 
  Mean Std. Deviation 
Q1ActualRate2006 85% 20% 
Q2ActualRate2006 87% 19% 
Q3ActualRate2006 88% 18% 
Q4ActualRate2006 89% 16% 
Q1ActualRate2007 90% 15% 
Q2ActualRate2007 91% 14% 
Q3ActualRate2007 92% 14% 
Q4ActualRate2007 93% 13% 
 
The estimated marginal mean graphs are shown in Figures 13 to 16. The Individual 
Measures were split up so that detail could be observed.  
Figure 13: Means of all rates over 2 years 
 
There is a significant linear trend of improvement through the 8 quarters studied.  
 Figure 14 shows all individual measures collected over two years for all hospitals 
in California. 
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Figure 14: Means by measure over 2 years 
 
The chart above is split below into Figures 15 and 16 for easier readability.
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The smoking cessation advice rate has a steady increase in rates from about 88% to 94% 
over two years. Other measures such as oxygen assessment are steady as they have less 
room to improve. Over all though, all measures in Figure 15 show an upward trend. 
Figure 16 shows the lower half of the measures from Figure 14. 
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Figure 16: Means by measure over 2 years 
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The lower performing measures show much more variability in improvement. 
 In Figure 17 composite rates in the three areas of care (heart failure, heart attack 
and pneumonia) are shown.  
 
Figure 17: Means by measure set over 2 years 
 
 
As provided in Figure 17, heart failure has the most improvement from 80% to about 
90%. It is also the lowest performer initially.  
For all of the hospital characteristic charts in Figure 18, we see differences by 
category. Large hospitals, those with more discharges, higher revenue and shorter lengths 
of stay have higher JCAHO quality rates. In all cases though, there is improvement from 
the first to the second year.  
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Figure 18: Mean rates by characteristics over 2 years 
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 Finally, to reflect back on the intervention, the rates were plotted for intervention 
and control hospitals separately in Figure 19. A clearly secular trend is observed in both 
the control and intervention groups.  
 
 
Figure 19: Mean rates by Intervention Group 








In this section, we restate each research question/hypothesis and reflect on the 
results as they relate to those areas. The chapter closes with general comments and future 
directions. 
 
Research Question 1 Restated 
 
Research Question 1: Does the threat of public reporting of smoking cessation 
rates affect hospital performance in this area?  
Hypothesis 1: When faced with public reporting of JCAHO smoking cessation rates in 
local media in a year, treatment hospitals will significantly improve their performance 
compared to control hospitals 
 
Intervention Design and Broad Outcomes 
 
During the initial design of the intervention, it was uncertain if the process would 
actually occur. The concept of randomizing a state’s hospitals seemed to be a lofty effort. 
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However, gathering data on the hospitals and using the concept of regions made the 
notion more tangible. In addition, the creation of JCAHO’s Quality Check with their 
continued support helped to develop the database in this study. While there was still a 
sizeable amount of data processing to complete, prior to the development of this database 
one would have to manually download individual portable documents for each hospital 
and extract the data. 
Next, the approach used in this intervention was quite novel: we informed 
hospitals of their performance and forthcoming publicity on the topic while offering a 
way to improve their performance. We were surprised to observe the complacency most 
hospitals had (in that they did not respond to our letter and training). Quality 
improvement is at the forefront of organized healthcare and smoking cessation 
advice/counseling at the bedside is a core measure of inpatient quality. Not to mention 
research has led to a vast amount of evidenced based medicine guidelines for it 
(Cromwell et al., 1997; National Cancer Policy Board, Institute of Medicine and National 
Research Council, 1998). Perhaps the hospitals were overwhelmed with other measures 
in the core set that are easily changed or considered more “clinical.” Implementation of a 
smoking cessation program may not have seemed feasible. Optimistically we hope that 
hospitals are at least encouraging their providers to give brief advice to quit smoking at 
the bedside since that is the bare minimum proven to be effective in research. It is also 
possible that high performers did not feel the need to improve or respond to the letter 
because they observed that they were above the mean.  
 
  72 
The Intervention Outcomes: Testing the Hypothesis 
 
In considering how to match regions, we first considered using JCAHO baseline 
data. However, this was not done since the data were only available six months after the 
start of the study. Also in 2005 when the study process was initiated, JCAHO rates were 
in major flux. More specifically the data collection tools may not have been in place at 
hospitals and therefore JCAHO surveys were sparse. As an alternative to individual 
matching, we used region characteristics with the assumption that JCAHO baseline rates 
would be comparable among regions with comparable populations, hospitals and 
economic resources. These variables used to match are shown in Table 2. However 
despite the efforts to match, we observed baseline differences between matched regions 
during the follow up analysis. 
To correct for these baseline differences, we used change scores. As shown in 
Table 4, there was a significant difference in change scores when comparing intervention 
and control hospitals. Furthermore, the control hospitals increased their cessation rate by 
8% and the intervention hospitals by 4%; interestingly, this was a significant conclusion 
in the direction opposite to our hypothesis. However, the fact that control hospitals had a 
lower cessation counseling/advice rate initially is a factor. The next table (5) shows that 
those hospitals that had lower initial smoking cessation advice/counseling rates had a 
much larger increase (24 percent point increase) versus those with higher initial baseline 
rates (0 percent point increase). This is intuitive in that those that are much lower 
performers have more room to improve. Improvement rates are likely approaching a 
ceiling.  
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While hypothesis one was incorrect, we demonstrated that there is overall 
improvement in performance across hospital regions and times. Referring to the table of 
paired comparisons (Table 3), where we compared each hospitals initial rate to their final 
rate, we see significant improvement in rates across the board. Hospitals in California 
(and likely nationally) are all reaching higher rates in smoking cessation. This 





Four hospitals participated in the training (with a few sending more than one 
representative). These included two private hospitals, a University hospital and an HMO. 
(The University hospital had already completed the training before but wanted extra 
training.) The HMO had change in rates from 77% to 93%. Interestingly, by separating 
out all of the same HMO from all of the data, we find that at the initial time, only 5 of 26 
hospitals had 100% smoking cessation rates. One year later, 17 of 26 hospitals had 100% 
smoking cessation rates. This may be indicative that the HMO is aggressively trying to 
improve their quality ratings; in California their marketing and image are being heavily 
publicized. They are also implementing universal EMR systems which are known to 
increase identification/contact of smokers. Therefore, this particular group which had a 
low starting rate may have had more funds and administrative support to attend training.  
The two private hospital systems were already high performing at initiation of the 
study with 100% rates (though in our initial letter with their older data, they were not at 
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100%). We cannot comment on whether the training had an effect beyond 100% rates 
(such as increasing the volume of patients counseled or offering better quality advice). 
Regardless, their attendance to training showed commitment to improvement. Finally the 
University Hospital was local to training and has a smoking cessation program in place 
already. Their attendance to the training may have helped to produce a few more 
interventionists or tighten their system.  
 
Design Limitations and Other Effects of the Intervention 
 
It was mentioned in the initial time period of the study, JCAHO data were sparse. 
More specifically, at that time, most hospitals had not yet differentiated their areas of care 
into heart attack, heart failure and pneumonia. The large amount of missing data was 
problematic for the research design used. Some treatment hospitals received letters with 
only one of the three areas of care having data. The “threat” of reporting may have been 
weak given we did not even have complete data. Now hospitals are becoming more 
aware of JCAHO data demands; the aforementioned barrier of data unavailability is 
becoming less apparent. JCAHO is now mandating hospitals to comply with Quality 
Check. Electronic medical records will help to increase data availability as well 
Now that data collection is improving, hospitals are able to better “check off” when 
measures are fulfilled. This may reflect a false improvement where clinicians can quickly 
mark process measures as once. It was already noted that the VA hospitals has used an 
electronic check system for years. Almost all VA hospitals have been reporting 100% 
rates since creation of Quality Check. For example, the 2004 JCAHO quality report for 
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the VA included in Staying Free disseminations studies reported a 100% rate for smoking 
cessation advice/counseling. However in an independent audit as part of our study we 
found that, only 4.2% of all smokers on medical inpatient units in Hospital A were 
actually enrolled in the Staying Free program, the only smoking cessation program 
offered to inpatients. There is a large, unexplained gap between the JCAHO reported 
rates of advice/counseling and the actual enrollment in the only program available. Given 
its ease of completion, the electronic “check” may be misleading--giving the impression 
that all patients received an “intervention” when it is unlikely that such was the case.  
On the other hand the near 100% rates may be real. This may reflect that with 
measurement, quality improves. However, the nature of the rate is that it approaches a 
maximum of 100%. The ceiling of improvement can confound results. Change in rates is 
more pronounced for initially lower performing regions. Therefore trends cannot be 
linear but they may approach asymptotes. Due to uncertainty of the final trends, linearity 
was assumed in the analysis. 
Also the fact that we used regions and not individual hospitals in pairing the 
randomized units caused extra variation in the data. It may have been that two hospitals 
in a region were so different from one another that the average rate of cessation was not a 
true indication of their values. However, it would have been difficult to match each 
hospital perfectly as well since the number of variables to consider that could affect the 
outcome are numerous (beds, patient population, location, geography, providers, revenue, 
etc).  
Another issue with the data is the fact that Pair A is so varied (large standard 
deviations in the group). This group has the largest weight in the analysis. If the region is 
  76 
too large so that hospitals in San Francisco Bay Area are not at all comparable to 
Southland 1, then the pairing may be invalid. Finally, Pair G could not be included at all, 
again due to insufficient data from JCAHO. It may have been wiser to use less geography 
to construct regions and more predefined algorithms. For example, using a few measures 
of hospitals characteristics, in addition to urban/city/rural setting we could have matched 
each individual hospital to another, regardless of geography.  
The timing may have been problematic as well. One year may not have been 
sufficient to implement a program to be reflected in JCAHO Quality Check. Even if a 
program did improve their smoking cessation services, documentation may not be in 
place in a year or there may be no formal referral process to impact the rates significantly. 
Those that attended training did so 3 months after receipt of the letter. Actual 
implementation/improvement after training would take at least a year. 
Another barrier to our efforts is lack of site resources for training to difficulty in 
fully implementing a program. For the latter concern, our training sessions provide case 
consultation to hospitals so they can best achieve desired results with personalized 
guidance. As for the former concern, we had established a website at 
http://bml.stanford.edu/center to offer the hospitals free resources to provide Staying 
Free. We also provided selected “consultation” through an updated “FAQ and Ask the 
Expert” page on the site. The final barrier was lack of hospital interest. Given the 
multitude of requirements and demands on hospitals today, our “threat” of publicity may 
not be of importance. This is crucial to recognize, since we are evaluating this new 
method.  
  77 
A hidden productive step in this intervention process is promotion of JCAHO 
Quality Check. By publicizing their measures in local media, we help to make the public 
more aware of their existence. This is useful for the quality effect because the consumer 
becomes more educated and empowered about their healthcare providers. Even if the 
community does not access the data, having it made public can help improve quality as 
hospitals become more aware of their transparency.  
This transparency presents threats to hospitals. For example, there is the threat 
that the hospital may be in an advertisement. If they perform poorly, that impacts image. 
If they are listed as having insufficient JCAHO data, that also reflects poorly upon the 
hospital as it demonstrates they may not have the infrastructure to produce compete 
JCAHO data, or that they are not active in quality assessment. This threat of publicity 
relates to Protection Motivation Theory.  
 
Review of the Theoretical Models 
 
Protection motivation theory (described in Chapter 2) had four components (Boer 
& Seydel, 1996; Rogers, 1983). The first was the perceived severity of the threat. It is 
possible that the letter sent to the hospital CEOs and administrators was not a high 
priority or very threatening or even read; this may have led to a low response rate. The 
threat of publishing their quality data may not have been as dreadful as other threats 
facing hospitals now. The second component is the perceived possibility that the threat 
will occur. In order to reinforce this, we should have sent reminder letters to the 
administrators. An even more bold approach would have been to try to contact each 
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recipient by phone to follow up and ask if they have any questions. The efficacy of 
positive preventative behavior is component three. Given that there was only a year to 
improve, a healthcare organization may not have perceived there was enough time to 
implement a positive change that would have been efficacious. This and shortage of 
resources lend to decreased self efficacy of adherence to a plan (component 4).  
The Berwick theory of change states that it requires discomfort and tension 
(Berwick, 2002). Furthermore it states that publicly reported data can lead to 
improvement through patient selection or assisting in provider change. It was intended 
that our intervention would function at both levels. First, the letter (public reporting) 
would help hospitals identify an area of improvement where change can occur: smoking 
cessation advice. Second, patients would observe public reports and this would affect 
selection. This intervention likely had less effect on the patient since prior research has 
shown that the patient is not as interested in public reporting of hospital quality data 
when compared to hospitals. Finally, Hibbard et al (2005) suggested that Berwick 
integrate a third component of how public reporting affects change: public image. This 
study was intended to directly influence public image of a hospital through the 
intervention. On a larger scale, it appears the existence of JCAHO data affects hospitals’ 
perception of public image. The secular increase in smoking cessation performance (and 
all other measure performance) demonstrates that hospitals are responding to JCAHO 
publication of data. First they are likely implementing better methods of collecting 
JCAHO performance data. Next, they are hopefully implementing means to better adhere 
to the measures. The motivation behind these changes is partly influenced by image: 
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JCAHO scores are part of a hospitals image and in order to profit, run and attract 
patients/staff, the hospital needs to preserve that image. 
The stronger motivation is financial. Based on the enactment of the Social 
Security Amendments of 1965, hospitals with Joint Commission accreditation were 
deemed to meet the Medicare hospital conditions of participation. This is important 
because for a health care organization to participate in and receive payment from the 
Medicare or Medicaid programs, it must meet the eligibility requirements for program 
participation, including a certification of compliance with the conditions of participation, 
or standards, set forth in federal regulations. This certification is based on a survey 
conducted by a state agency on behalf of the Centers for Medicare & Medicaid Services 
(CMS) or through use of JCAHO accreditation. In addition to the CMS funding 
incentives already in place, there is a prospect for Pay for Performance models. In mid 
2007, the CMS prepared and submitted a proposal to Congress outlining its draft plan for 
a new program of financial incentives tied to hospital performance.  
It involved a value-based purchasing (VBP) strategy to reward providers for 
meeting measures of healthcare quality. The root of this was in 2005 when The Deficit 
Reduction Act (DRA) of 2005 authorized CMS to develop a VBP plan for Medicare 
hospital services beginning in 2009. Since the development of the initial plan in 2007, the 
Senate Finance Committee has been revising the plan for implementation. Hospitals are 
aware of the prospect of a pay for performance model in which there are benchmarks sets 
and extra incentives for high performers. Because CMS works with JCAHO measures, 
hospitals are inclined on their own to improve on those measures (U.S. Department of 
Health and Human Services, 1997). 
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The final theory presented was the push-pull-capacity model (Curry, 2000). 
Hospital administrators and providers are aware of the push of inpatient smoking 
cessation research success. Our letter intended to offer more of a push of evidence of 
success in programming through free training. The market pull is the same pull described 
by Berwick: public reporting and publicity through JCAHO and our advertisement also 
fueled by federal money. Finally we helped to increase capacity by offering free training 
to implement smoking cessation methods based on their infrastructure. It was predicted 
that the combination of these three factors would lead to measured change. While the 
intervention had no effect, JCAHO performance measures as related to Centers for 
Medicare & Medicaid Services funding on their own may contribute to the push and pull. 
The scientific push is the fact that JCAHO acknowledges smoking cessation to be 
important enough to be a core measure in accreditation for funding. The pull is that 
JCAHO measures have credibility in the healthcare market in conjunction with CMS.  
 
Research Question 2 Restated 
 
Research Question 2: What factors affect a hospitals smoking cessation rates and 
change in those rates? 
Hypothesis: This is an exploratory analysis intended to find what, if any, hospital 
characteristics are stronger in predicting improvement. Factors include bed size, length of 
stay, revenue and discharges. 
 
Regression of change based on other hospital characteristics 
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The regression model in Table 7 built to predict change in rates produced 
interesting results. Change was significant correlated independently to initial rate, 
intervention, beds, average length of stay and revenue. Controlling for each variable, in 
the actual regression model, composite baseline rate was significant as was length of stay. 
We discuss the latter finding first. Length of stay was inversely related to change in rate. 
That is, hospitals where patients stay shorter periods had greater increases in smoking 
cessation rates. This is counterintuitive since longer stays usually indicate more 
opportunities for advice. On the other hand, more efficient hospitals may have more 
efficient advice methods as well. In a future study or in future training outreach efforts it 
may be useful to target hospitals with longer stays since it appears that those are lower-
performing and because smoking cessation advice may have a bigger impact with 
patients who stay in the hospital longer.  
The second more interesting and meaningful variable is composite baseline rate. 
This was also negative, indicating that hospitals with lower baseline rates had greater 
increases in advice rates. This reaffirms prior conclusions that using JCAHO rates in this 
type of a study are difficult because eventually all hospitals reach 100%. In fact, given 
the linear curve estimated using all measures in Table 11, California hospitals in theory 
would reach 100% quality rates across the board by the last quarter of 2009. Clearly the 
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The main concerns related to research question two are with data. Fortunately the 
data that we analyzed were public. Therefore little or no IRB approval is required. On the 
other hand, this public data presented a wealth of information. While this was useful, it 
may have also been a bit overwhelming. It was important to predefine variables of 
interest, limit analyses to California and select specific procedures to prevent making 
multiple comparisons.  
A second point of concern in this section relates to data availability. Because of 
missing JCAHO data and even more patchy American Hospital Database information, the 
number of points used to build this regression model was less than desired. Data from 
other sources on hospital characteristics could have filled the gaps. However, because 
each source has their own definitions of revenue and discharges, it was decided to not add 
inconsistent information. More complete data on hospital characteristics may have helped 
produce more meaningful results. In addition to the regression analysis this problem and 
concern also applies to the GLM section below. 
 
Research Question 3 Restated 
 
Research Question 3: What effect does the existence of JCAHO performance 
measures have on Hospital Quality (as defined by those measures)? If there is an effect, 
what areas of care are most impacted? 
Hypothesis 3a: Over a two year period, hospitals in California will demonstrate 
improvement in JCAHO smoking cessation advice rates. 
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Hypothesis 3b: Over a two year period, performance on all measures assessed by JCAHO 
will improve. 
Hypothesis 3c: Hospitals will show greater improvements in performance for measures 
that assess process rather than outcome. (Smoking cessation advice is an example of a 
JCAHO process measure.)  
 
Design Considerations  
 
In Table 10, we present the Generalized Linear Model ANOVA to examine how 
performance rates change with hospital characteristics. The decision to divide the hospital 
characteristics into two categories for the generalized linear models was to make a simple 
model that did not make too many comparisons. The first point is for understandability; 
by dividing variable into two groups such as low revenue and high revenue, we can easily 
observe a trend if any are present and not struggle to make a conclusion. Second, if too 
many divisions are made, the degrees of freedom increases and the chance for type II 
error increases. The last statistical note is the use of Greenhouse-Geissner corrections, 
recommended based on the sphericity assumptions of the repeated measures model; this 
helps to reduce errors due to inequality of variances.  
The first graph in this section (Figure 13) has no between subjects’ considerations 
and shows a significantly linear increase in all measures of quality over the 8 quarters. 
Again, the linearity in the next year may be less obvious since we asymptotically 
approach 100%. However, it is important to note again the secular trend of improvement 
in California hospitals. Having quality measures in place and collecting data improves 
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quality since those elements relate to funding. It may be that hospitals are better 
documenting information through electronic medical records now in place. On the other 
hand, the quality goals for accreditation from JCAHO may help to encourage provider 
adherence to implementation of evidence based activities. Finally, the increased 
awareness from hospitals that their data is made public may also help to increase rates. 
Referring to Figures 14-16 with individual measures, among all the measures 
shown, smoking cessation had the most steady improvement. This echoes the findings in 
the original JCAHO data report (Williams et al., 2005). Again we see the problems of 
measures that are high initially; they do not improve much. Looking specifically at 
individual measures, we can make some conclusions. Oxygen assessment is consistently 
high; this is likely due to the fact that it is a vital on most charts. That is, it is recorded 
just as blood pressure, heart rate and temperature are recorded. Also no service is given 
here; just a measurement is taken, so 100% rates should already be in place. The next top 
three lines are in the area of medication given. This is a bit more difficult since action 
must actually be taken to fulfill these requirements, but for heart patients, aspirin and beta 
blockers have also been in place for a while. Factors such as blood cultures for 
pneumonia may have seasonal variation, lending to the jagged curve. Based on the load 
of pneumonia patients, caregivers may be more or less burdened and more or less 
cognizant of the importance of blood cultures. Hospital advisories also affect culture 
requests.  
The lower performing measures in Figure 16 have a couple of promising steady 
increases including discharge instructions and pneumococcal vaccines. While discharge 
instructions should be universal in care, an item like pneumococcal vaccination for 
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pneumonia patients may be increasingly popular. Guidelines for this are changing 
currently and hospitals may also hesitate for universal vaccination due to shortages. (It 
would be interesting to follow infection measures for 2009 during emergence of H1N1.) 
When separating quality ratings by area of care (Figure 17), we see heart attack 
care as having the highest initial and final rate with heart failure at the bottom. Table 12 
displays a list of measures in each measure set from the JCAHO website (Joint 
Commission on Accreditation of Healthcare Organizations, ). 
  
Table 12: Individual Measures in Measure Sets 
Heart Attack Care:   
• ACE inhibitor or ARB for LVSD  
• Adult smoking cessation advice/counseling  
• Aspirin at Arrival  
• Aspirin prescribed at discharge 
• Beta blocker at arrival  
• Beta blocker prescribed at discharge   
• Inpatient mortality 
• PCI Received Within 120 Minutes of Hospital Arrival 
• Thrombolytic Agent Received Within 30 Minutes of Hospital Arrival 
• Time to PCI  
• Time to thrombolysis 
 
Heart Failure Care:  
• ACE inhibitor or ARB for LVSD  
• Adult smoking cessation advice/counseling  
• Discharge Instructions  
• LVF assessment  
 
Pneumonia:  
• Adult smoking cessation advice/counseling  
• Antibiotic timing  
• Blood cultures for pneumonia patients admitted through the Emergency Department   
• Blood cultures for pneumonia patients in intensive care units  
• Initial Antibiotic Received Within 8 Hours of Hospital Arrival  
• Initial Antibiotic Received Within 4 Hours of Hospital Arrival  
• Initial Antibiotic Selection for CAP in Immunocompetent – ICU Patient  
• Initial Antibiotic Selection for CAP in Immunocompetent – Non ICU Patient  
• Influenza Vaccination  
• Oxygenation assessment   
• Pneumococcal vaccination  
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Heart failure care, the lowest performer, has the least amount of indicators to 
fulfill. It would seem that hospitals are able have higher quality rates when there are less 
requirements demanded of them. Also heart failure had the most room to improve. Heart 
attack measures include 4 on admission and discharge drugs which may make fulfilling 
those easier since they are linked.  
 Next, the hospital characteristic graphs in Figures 18 show distinct differences in 
quality trends. Larger hospitals and those with higher revenue have higher initial and 
final quality rates. It is reasonable to assume that in California, hospitals that are larger 
with more resources have a more vested in interest in maintaining higher quality initially. 
The less equipped hospitals are following, but still are behind. Quality improvement 
initiatives need to focus on helping disadvantaged hospitals meet guidelines. In smoking 
cessation for example, where a service is required, less staffed hospitals may not have the 
resources to devote to this. Vaccinations are another prime example where there may be 
limits on availability.  
 
Final Comments on Public Reporting, Responses and Quality Measures 
 
To begin to summarize some of the major concerns of the intervention design, we 
note that it is questionable if patients will change their healthcare providers based on this 
type of data. While the individual patient may not have this option, insurance companies, 
work places and larger payers can respond to quality information. “Pay for performance” 
is a concept that will also seek out quality information JCAHO notes. Finally with notion 
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of universal healthcare on the horizon, the patient may have more control over their 
health and these measures may affect insurance providers. (We hope that these measures 
are not lost in efforts are not lost in future efforts to reach more patients with national 
healthcare plans, and that instead they are enhanced.) Even if the data have no effect, 
quality in hospital care becomes even more important as the reach of patients is even 
greater. There also remains the question of whether patients will also access JCAHO 
quality data. 
In terms of the sub benchmark rates of smoking cessation advice in hospitals, it is 
important to note that this is disheartening. The evidence has been long standing that 
smoking cessation is important anytime a health provider encounters a smoker. Just a 
sentence is required to initiate change. No treatment, equipment or follow up is needed to 
meet this guideline (Lancaster & Stead, 2004). The fact that 100% of smokers are not yet 
receiving that simple advice may seem to not be a great reflection on hospitals. It is our 
hope that documentation is to blame for this and not a harsh reality about priorities in 
medical care delivery. What is admirable is the improvement noted in this study in just 
one year. If this improvement continues, then we will see near 100% advice benchmarks 
met soon. 
JCAHO only uses a process measure where advice can be as simple as one 
sentence given to the patient at the bedside and can also vary (DeFrances & Hall, 2007). 
Ultimately outcome measures need to be tracked to effectively assess conditions. 
However, given the laxity of the current process measure, hospitals can hopefully 100% 
rates. More and more studies find that JCAHO processes can not yet be linked to 
outcome (Griffith, Knutzen, & Alexander, 2002). (Interestingly in JCAHO 
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documentation, they note that their current emphasis is on process and not outcomes of 
care (Joint Commission on Accreditation of Healthcare Organizations, 2008)). 
Earlier it was mentioned that rates will soon approach this asymptote. How does 
this affect research studies such as these? Results become less meaningful, as was 
apparent in the previous chapter. In order to produce meaningful data, JCAHO should 
adopt a policy of creating outcome measures. In smoking cessation advice, the outcome 
is obvious: success at say, six months. Other measures are more useless without 
outcomes. For example, left ventricular function assessment is not of any use if action is 
not taken on that assessment. The patient’s response relies on the assessment, timing, 
action, follow up and so on. A better measure would take into account the goal of the 
assessment.  
 
Impact of Findings: Audience and dissemination of research 
 
The first audience was the directors and administrators of hospitals. They were 
contacted in the intervention process and will hopefully remain aware of the results and 
JCAHO data. We know that this is almost guaranteed as a result of funding 
threats/incentives. The second audience was the health care consumer population in the 
treatment regions who were provided information about their hospitals' performance on 
this measure through local media. The third "audience," and from a patient centered care 
perspective the most important one, will be those individuals who are hospitalized for 
heart attack, heart failure and pneumonia care and used tobacco before admission. 
Hopefully by stimulating change the patients will be provided with better care. A fourth 
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audience will be policy makers, JCAHO and other groups and individuals who might find 
the strategy useful, should it be effective. In addition to this group, we anticipate those 
involved in health care quality improvement will be interested in the method used. Other 
possible groups include those that study social marketing. 
 
Future Goals and Directions 
 
In the initial design of this study we planned to pilot the intervention in 
California, then expand efforts to the entire country. A sample randomization map of US 
regions is shown in Figure 22. In order to complete such a study, it would also be more 
useful to have matched hospitals and regions on a more detailed basis. A real effect or 
change may be more apparent if the period of analysis is longer than 1 year. Because of 















For example, it would be useful to assess the assessment process. A study in 
which hospitals track outcome measures in addition to smoking cessation advice rates 
could be designed. For those patients in the JCAHO survey, follow up through EMR 
could assess smoking status after 6 months. This could be piloted in select JCAHO 
hospitals and compared to control hospitals to assess whether adding an outcome to a 
process measure increases adherence to the process measure.  
Next, a major finding in this paper was that the act of data collection/public 
reporting alone lead to improvement on the hospital end. A future study could help 
determine how patients (the consumer) respond. Mass publication of JCAHO data 
availability could be done and randomized surveys of patients and healthcare staff would 
reveal the public impact of JCAHO data presence. 
 
Figure 20: Sample Division of US into regions 
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As healthcare changes in our country, the consumer is becoming more aware of 
high quality versus low quality care. Right now is an ideal time to publicize JCAHO data 





While we did not demonstrate efficacy of a new intervention, we did show that 
recording/publicizing quality rates to the public and to health care organizations affects 
change both indirectly (image) and directly (financially); furthermore this helped to 
demonstrate the impact JCAHO has on quality. While the drive to improve is likely 
financial, there is a potential for image to play a part. Regardless of the cause, for the 
sake of the health of our nation, it is reassuring to know that smoking cessation advice 
rates and other quality measures are on the rise.  
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